Steroids used to desensitize penicillamine allergy in Wilson disease

Hui Ling Hsu, Fu Chen Huang, Yen Hsuan Ni*, Mei Hwei Chang

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

6 Scopus citations

Abstract

Patients with Wilson disease require life-long treatment and penicillamine is the drug of choice. We present a 14-year-old boy with Wilson disease who developed hypersensitivity reaction 2 days after starting penicillamine therapy. His symptoms included fever, maculopapular rash and lip edema. The allergic reaction disappeared when penicillamine was discontinued, but relapsed after reinstituting penicillamine at a lower dose. Desensitization was attempted by introducing steroid therapy, the dose of 0.7 mg per kilogram per day of prednisolone for 2 days, then penicillamine was successfully tolerated. Subsequent tapering of the daily prednisolone dose was performed till it was discontinued one month after treatment began. We suggest that concomitant use of steroid and penicillamine should be used for the treatment of patients who develop penicillamine intolerance.

Original languageEnglish
Pages (from-to)448-450
Number of pages3
JournalZhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui
Volume40
Issue number6
StatePublished - 11 1999
Externally publishedYes

Keywords

  • Desensitization
  • Penicillamine
  • Steroids
  • Wilson disease

Fingerprint

Dive into the research topics of 'Steroids used to desensitize penicillamine allergy in Wilson disease'. Together they form a unique fingerprint.

Cite this